SCHEMBL3832435

SCHEMBL3832435

Nc1ncnc2c1c(I)nn2C(CF)CF

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADK P55263 8/20 0.49
RET P07949 4/20 0.47
DYRK3 O43781 3/20 0.47
RPS6KB1 P23443 3/20 0.47
CSNK1A1 P48729 3/20 0.47
CSNK1D P48730 3/20 0.47
CLK2 P49760 3/20 0.47
IRAK1 P51617 3/20 0.47
DYRK1A Q13627 3/20 0.47
SLK Q9H2G2 3/20 0.47
CLK4 Q9HAZ1 3/20 0.47
SRC P12931 3/20 0.47
KDR P35968 3/20 0.47
CDK1 P06493 2/20 0.47
ROS1 P08922 2/20 0.47
CDK2 P24941 2/20 0.47
CDK5 Q00535 2/20 0.47
NTRK3 Q16288 2/20 0.47
PRKD3 O94806 2/20 0.47
MAP4K4 O95819 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4572206 0.85 SRC (0.47) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL868687 0.80 ABL1 (0.58) RETSRCKDREGFRPIK3CD
SCHEMBL4572197 0.78 SRC (0.54) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL4572199 0.78 SRC (0.54) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL4572200 0.78 SRC (0.54) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL4572203 0.75 SRC (0.44) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL20263231 0.73 RET (0.42) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL15956509 0.72 SRC (0.47) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL22430336 0.72 ADK (0.51) ADKRETDYRK3RPS6KB1CSNK1A1
SCHEMBL22748995 0.72 DYRK3 (0.51) ADKRETDYRK3RPS6KB1CSNK1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730148-A4 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LAB (US) 2009-08-19 EP disclosed
EP-1730148-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS Abbott Laboratories (US) 2006-12-13 EP disclosed
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABBOTT LABORATORIES 2006-02-02 US disclosed
WO-2005074603-A2 AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS ABBOTT LABORATORIES (US) 2005-08-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060025383-A1 Aminobenzoxazoles as therapeutic agents ABL1, MAP3K19, MAP3K20 ADK 144/4885RET 848/4885DYRK3 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.